POST EVENT REPORT

11 - 12 March 2026 | Marina Bay Sands Expo and Convention Center, Singapore

Attendees

Companies

Speakers

MESSAGE FROM THE ORGANISER

Clinical Trials Festival Asia 2026 welcomed 166 attendees, 28 expert speakers, and 82 organisations, creating a focused forum for advancing clinical development across the Asia-Pacific region.

Held alongside Biologics Manufacturing Asia 2026, the event brought together professionals responsible for clinical operations, clinical development, trial innovation, patient engagement, regulatory strategy, and data management from global pharmaceutical companies, regional biopharma organisations, CROs, and technology providers. The conference provided a platform to exchange insights on accelerating trial timelines, improving patient recruitment and retention, integrating decentralised and hybrid trial models, and navigating the evolving regulatory landscape across Asia.

Across the programme, discussions focused on key priorities shaping the future of clinical trials in the region, including patient-centric trial design, AI-driven clinical development, decentralised trials, real-world data integration, digital biomarkers, and strengthening regional clinical trial infrastructure. Speakers shared practical strategies for improving operational efficiency while ensuring data quality, regulatory compliance, and broader patient participation.

With organisations represented from Singapore, South Korea, Japan, India, Australia, and Southeast Asia, Clinical Trials Festival Asia 2026 continues to grow as an important platform for collaboration and knowledge exchange across the Asia-Pacific clinical trials ecosystem.

Sincerely, IMAPAC

Attendee Breakdown

By Country

By Job Title

By Industry

Testimonials

“Good team, clever techniques to bring people in contact. Appreciate their effort and help.”

Product & Sales Manager, DrM Group, Switzerland

“Great experience! Nice speakers and exhibitions!”

CEO, HoneyBear Biosciences, Inc., Taiwan

“Friendly partnership, staff are very helpful.”

R&D Director, HyQure Biotech, China

“The team was very friendly and helpful. They were committed to scheduling 1-to-1 meetings and ensuring it went smoothly.”

BDM, SGS

“Good selection of topics and speakers.”

Senior Scientist, Bioprocessing Technology Institute, A*STAR

“Imapac always manages to invite some very inspiring speakers.”

Director, Asset Lead, EDDC

“Overall, we believe the event was very well organized and successful. From an exhibitor’s perspective, the arrangement of 1-to-1 meetings was particularly useful and added significant value.”

Business Development Director, Pfanstiehl

“Thank you so much for organizing such a well-run event. It was truly a pleasure to contribute, and I enjoyed the atmosphere and engagement from the audience during the event.”

Corporate Performance Specialist, Biofarma

“It was a very valuable conference experience. I was pleased to have the opportunity to present and discuss our technology with peers in the field, which led to several new and meaningful engagements. The meeting also offered a strong scientific programme, and it was inspiring to hear high-quality work from other groups. Beyond the content itself, the conference was especially useful for building new connections and opening the door to potential future collaborations.”

CTO, Singzyme, Singapore

"Insights from industry leaders are valuable and cannot be found easily online"

Technical Steward, BioNTech, Singapore

“Thanks for organizing BioSupply Chain Asia, it was a good event and I have learnt a lot.”